Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) (vol 109, pg 112, 2007)

被引：0
|
作者：
Goodeve
机构：
来源：
BLOOD | 2008年 / 111卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3299 / 3300
页数：2
相关论文
共 50 条
  • [1] Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
    Goodeve, Anne
    Eikenboom, Jeroen
    Castaman, Giancarlo
    Rodeghiero, Francesco
    Federici, Augusto B.
    Batlle, Javier
    Meyer, Dominique
    Mazurier, Claudine
    Goudemand, Jenny
    Schneppenheim, Reinhard
    Budde, Ulrich
    Ingerslev, Jorgen
    Habart, David
    Vorlova, Zdena
    Holmberg, Lars
    Lethagen, Stefan
    Pasi, John
    Hill, Frank
    Soteh, Mohammad Hashemi
    Baronciani, Luciano
    Hallden, Christer
    Guilliatt, Andrea
    Lester, Will
    Peake, Ian
    BLOOD, 2007, 109 (01) : 112 - 121
  • [2] Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
    Budde, U.
    Schneppenheim, R.
    Eikenboom, J. .
    Goodeve, A.
    Will, K.
    Drewke, E.
    Castaman, G.
    Rodeghiero, F.
    Federici, A. B.
    Batlle, J. .
    Perez, A.
    Meyer, D.
    Mazurier, C.
    Goudemand, J.
    Ingerslev, J.
    Habart, D.
    Vorlova, Z.
    Holmberg, L.
    Lethagen, S.
    Pasi, J.
    Hill, F.
    Peake, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (05) : 762 - 771
  • [3] Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD): a rebuttal
    Favaloro, E. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) : 1999 - 2001
  • [4] Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD): reply to a rebuttal
    Budde, U.
    Federici, A. B.
    Goodeve, A.
    Eikenboom, J.
    Schneppenheim, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) : 2002 - 2003
  • [5] Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
    Haberichter, Sandra L.
    Castarnan, Giancarlo
    Budde, Ulrich
    Peake, Ian
    Goodeve, Anne
    Rodeghiero, Francesco
    Federici, Augusto B.
    Batlle, Javier
    Meyer, Dominique
    Mazurier, Claudine
    Goudemand, Jenny
    Eikenboom, Jeroen
    Schneppenheim, Reinhard
    Ingerslev, Jorgen
    Vorlova, Zdena
    Habart, David
    Holmberg, Lars
    Lethagen, Stefan
    Pasi, John
    Hill, Frank G. H.
    Montgomery, Robert R.
    BLOOD, 2008, 111 (10) : 4979 - 4985
  • [6] Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD
    Castaman, Giancarlo
    Lethagen, Stefan
    Federici, Augusto B.
    Tosetto, Alberto
    Goodeve, Anne
    Budde, Ulrich
    Batlle, Javier
    Meyer, Dominique
    Mazurier, Claudine
    Fressinaud, Edith
    Goudemand, Jenny
    Eikenboom, Jeroen
    Schneppenheim, Reinhard
    Ingerslev, Jorgen
    Vorlova, Zdena
    Habart, David
    Holmberg, Lars
    Pasi, John
    Hill, Frank
    Peake, Ian
    Rodeghiero, Francesco
    BLOOD, 2008, 111 (07) : 3531 - 3539
  • [7] Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
    Eikenboom, J
    Van Marion, V
    Putter, H
    Goodeve, A
    Rodeghiero, F
    Castaman, G
    Federici, AB
    Batlle, J
    Meyer, D
    Mazurier, C
    Goudemand, J
    Schneppenheim, R
    Budde, U
    Ingerslev, J
    Vorlova, Z
    Habart, D
    Holmberg, L
    Lethagen, S
    Pasi, J
    Hill, F
    Peake, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) : 774 - 782
  • [8] Previously missed mutations in the MCMDM-1VWD type 1 von Willebrand disease study
    Alyami, N. H.
    Hampshire, D.
    Goudemand, J.
    Castaman, G.
    Federici, A. B.
    Cartwright, A.
    Peake, I. R.
    Goodeve, A. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 415 - 415
  • [9] Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
    Tosetto, A.
    Rodeghiero, F.
    Castaman, G.
    Bernardi, M.
    Bertoncello, K.
    Goodeve, A.
    Federici, A. B.
    Batlle, J.
    Meyer, D.
    Mazurier, C.
    Goudemand, J.
    Eikenboom, J.
    Schneppenheim, R.
    Budde, U.
    Ingerslev, J.
    Vorlova, Z.
    Habart, D.
    Holmberg, L.
    Lethagen, S.
    Pasi, J.
    Hill, F.
    Peake, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 715 - 721
  • [10] Re-evaluation of sequence variation in type 1 von Willebrand disease in the MCMDM-1VWD cohort
    Goodeve, A. C.
    Hampshire, D.
    Batlle, J.
    Budde, U.
    Castaman, G.
    Eikenboom, H. C. J.
    Federici, A. B.
    Schneppenheim, R.
    Peake, I. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 413 - 414
12345